Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.
An opinionated take on NEJM highlights for May 2019
By
Marc Herant
NEJM
Read more
It’s in the brain: An opinionated take on NEJM highlights for April 2019
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for March 2019
By
Marc Herant
NEJM
Read more
February was short and cold: An opinionated take on NEJM highlights for February 2019
By
Marc Herant
NEJM
Read more
Methods towards better care: An opinionated take on NEJM highlights for January 2019
By
Marc Herant
NEJM
Read more
On the uses of genetic information in disease: An opinionated take on NEJM highlights for December 2018
By
Marc Herant
NEJM
Read more
Eating your way out of disease: An opinionated take on NEJM highlights for November 2018
By
Marc Herant
NEJM
Read more
T-cells are everywhere: An opinionated take on NEJM highlights for October 2018
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for September 2018
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for August 2018
By
Marc Herant
NEJM
Read more
What’s harder, making new drugs or improving care delivery at scale? An opinionated take on NEJM highlights for July 2018
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for June 2018
By
Marc Herant
NEJM
Read more
Struggling: An opinionated take on NEJM highlights for May 2018
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for April 2018
By
Marc Herant
NEJM
Read more
Disease as an information defect
By
Marc Herant
Biopharma
Read more
EHRs + Genomics = Drugs? – An opinionated take on NEJM highlights for March 2018
By
Marc Herant
NEJM
Read more
An opinionated take on NEJM highlights for February 2018
By
Marc Herant
NEJM
Read more
Two steps forward, one step back: an opinionated take on NEJM highlights for January 2018
By
Marc Herant
NEJM
Read more
A golden age for gene therapy: an opinionated take on NEJM highlights for December 2017
By
Marc Herant
Biopharma
,
NEJM
Read more
Gene therapy, headaches, and tattoos: an opinionated take on NEJM highlights for November 2017
